21(top 2%)
papers
712(top 2%)
citations
12(top 2%)
h-index
17(top 2%)
g-index
21
all documents
845
doc citations
226
citing journals

Top Articles

#TitleJournalYearCitations
1Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysisEuropean Heart Journal2022341
2Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD TrialJournal of the American Society of Nephrology: JASN202289
3Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 DiabetesJournal of the American College of Cardiology202174
4Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor TherapyKidney International Reports202273
5Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenoneNephrology Dialysis Transplantation202250
6Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP‐1RA treatment: A subgroup analysis from the FIDELIO‐DKD trialDiabetes, Obesity and Metabolism202241
7Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE resultsNephrology Dialysis Transplantation202232
8Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 DiabetesHypertension202224
9Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO‐DKD trialEuropean Journal of Heart Failure202223
10Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetesJournal of Hypertension202323
11Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD StudyDiabetes Care202220
12A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney diseaseCKJ: Clinical Kidney Journal202319
13Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysisEuropean Heart Journal - Cardiovascular Pharmacotherapy202312
14Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 DiabetesClinical Journal of the American Society of Nephrology: CJASN202312
15Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular diseaseEuropean Heart Journal - Cardiovascular Pharmacotherapy20226
16Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baselineDiabetes, Obesity and Metabolism20234
17FC 090EFFECTS OF FINERENONE ON CARDIORENAL OUTCOMES IN BLOOD PRESSURE SUBGROUPS IN PATIENTS WITH CKD AND T2DNephrology Dialysis Transplantation20212
18POS-350 FINERENONE IN MILD TO SEVERE CHRONIC KIDNEY DISEASE AND TYPE 2 DIABETES: THE FIDELITY PRESPECIFIED POOLED ANALYSISKidney International Reports20220
19MO198: Outcomes with Finerenone in Patients with Stage 4 Chronic Kidney Disease and Type 2 Diabetes: A Fidelity Subgroup AnalysisNephrology Dialysis Transplantation20220
20Finerenone and Cardiorenal Outcomes by History of Cardiovascular Disease in Patients with Type 2 Diabetes: Fidelity AnalysesAmerican Heart Journal20220
21Finerenone in Mild to Severe Chronic Kidney Disease and Type 2 Diabetes: A Fidelity Subgroup Analysis in Patients with Heart FailureAmerican Heart Journal20220